Screening of angiogenesis inhibitors using a 3D vascular microfluidic chip to achieve contraception

Biochem Biophys Res Commun. 2019 Jul 12;515(1):92-98. doi: 10.1016/j.bbrc.2019.05.110. Epub 2019 May 22.

Abstract

Angiogenesis plays a vital role in the process of embryo implantation, as it improves endometrial receptivity and guides embryo implantation, thus creating a favorable environment for subsequent development of the embryo. Hence, a theory of achieving contraception by inhibiting angiogenesis was put forward. Here, we screened the drugs inhibiting angiogenesis using cell scratch wound assay and a 3D biomimetic vascular microfluidic chip, then observed the effect of them on contraception by injecting these drugs into fertilized mice and observing if the embryos were implanted. We preliminarily verify the feasibility of contraception by inhibiting angiogenesis and gives a new direction in the development of contraceptive pills.

Keywords: 3D biomimetic blood vessel; Angiogenesis; Contraception; Drug screening; Microfluidic chip.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / isolation & purification
  • Angiogenesis Inhibitors / pharmacology*
  • Animals
  • Cells, Cultured
  • Contraception*
  • Drug Evaluation, Preclinical / methods
  • Embryo Implantation / drug effects*
  • Embryo, Mammalian / diagnostic imaging
  • Embryo, Mammalian / drug effects*
  • Embryo, Mammalian / embryology
  • Female
  • Fertilization / drug effects*
  • Human Umbilical Vein Endothelial Cells / cytology
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / physiology
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Mice, Inbred ICR
  • Microfluidics / methods*

Substances

  • Angiogenesis Inhibitors